Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Schwerte

15 clinical trials in Schwerte, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Schwerte at a glance
15
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

15 trials in Schwerte

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Solti Group
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:Universitaetsklinikum Ulm AöR
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:Medica Scientia Innovation Research S.L.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Back pain

Not recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Schwerte

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on different subtypes of early breast cancer, including HR+/HER2-, triple-negative, and HER2+ variants. These trials aim to evaluate innovative treatment approaches and improve patient outcomes.

  • HR+/HER2- Treatment Optimization
  • Triple-Negative Breast Cancer Therapy
  • HER2+ Treatment Strategies

Advanced research combining standard endocrine therapy with novel therapeutic agents to enhance treatment effectiveness.

02 Neuropathic Pain Management

Innovative clinical research exploring treatments for various forms of chronic neuropathic pain, including diabetic polyneuropathy and post-operative conditions.

  • Diabetic Polyneuropathy
  • Post-operative Neuropathy
  • Central Neuropathy

Evaluating new therapeutic approaches for managing chronic pain conditions with AP707 as an add-on treatment.

03 Chronic Pain Studies

Focused research on chronic back pain and various pain management strategies, investigating novel therapeutic interventions for improved patient care.

  • Back Pain Management
  • Pain Treatment Optimization
  • Add-on Therapy Assessment

Clinical evaluations aimed at enhancing current pain management protocols and patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.